RecruitingNot ApplicableNCT06601777

Evaluation of the Effectiveness, Safety, and Cost of a Smart Hospital System for Patients With Chronic Obstructive Pulmonary Disease

Evaluation of the Effectiveness, Safety, and Cost of a Smart Hospital System for Patients With Chronic Obstructive Pulmonary Disease: Prospective Multicenter Randomized Controlled Trial

Sponsor

Yonsei University

Enrollment

198 participants

Start Date

Sep 5, 2024

Study Type

INTERVENTIONAL

Conditions

Chronic Obstructive Pulmonary Disease

Summary

This study aims to analyze the effectiveness/safety/cost of the Smart Homespital system that provides a service that allows patients with Chronic Obstructive Pulmonary Disease to easily access and use biosignals generated using biosignal collection medical equipment at home.

Eligibility

Min Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a "smart hospital" digital health system — which monitors patients with COPD (chronic obstructive pulmonary disease) remotely using connected devices — can improve care, safety, and cost-effectiveness compared to usual care. **You may be eligible if...** - You have been diagnosed with COPD - Your breathing tests show significant impairment (reduced lung function on spirometry or low lung diffusion capacity) **You may NOT be eligible if...** - You decline to participate - You are unable to use the medical device equipment required for the study - You are expected to be unavailable or difficult to follow up during the study period - You have difficulty communicating verbally - You are bedridden or completely unable to exercise due to severe heart or breathing problems - You are currently receiving a hospital-based rehabilitation program Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALImmediate application of the Smart Homespital system

The Smart Homespital system can be applied for the first 3 months (12 weeks), and then the primary and secondary variables will be evaluated at 3, 6, 9months. While applying the Smart Homespital system, exercise three times a week, measure sleep twice a week, and questionnaire assessments (mMRC, CRQ, EQ-5D, K-CESD) are conducted once every two weeks.

BEHAVIORALDelayed application of the Smart Homespital system after 3 months

The waiting list-control group will receive general medical services for the first 3 months and will receive a Smart Homespital system for 3-6 months. Primary and secondary variables will be monitored between 3, 6, and 9 months. While applying the Smart Homespital system, exercise three times a week, measure sleep twice a week, and questionnaire assessments (mMRC, CRQ, EQ-5D, K-CESD) are conducted once every two weeks.